Global /India /Healthcare /Drug Manufacturers - General /SMSPHARMA
chevron_leftBack
SMS Pharmaceuticals Ltd. logo

SMS Pharmaceuticals Ltd.

SMSPHARMA
NSE: SMSPHARMA Delayed
403.70INR -1.6%
4.23 USD
As of 7 June 2026, SMS Pharmaceuticals Ltd. has a market cap of $401.11M USD, ranking #16660 globally and #896 in India. It ranks #1514 in the Healthcare sector, and #551 in the Drug Manufacturers - General industry.
Global Rank
16660
Country Rank
896
Sector Rank
1514
Industry Rank
551
Key Stats
Market Cap
$401.11MUSD
38.41B INR
Enterprise Value
$426.21MUSD
40.65B INR
Revenue (TTM)
$93.69MUSD
8.97B INR
EBITDA (TTM)
$17.82MUSD
1.7B INR
Net Income (TTM)
$9.36MUSD
895.91M INR
EBITDA Margin
19%
Profit Margin
10%
PE Ratio
42.7
PS Ratio
4.3
PB Ratio
5.3
EV/EBITDA
23.5
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Ramesh Potluri open_in_new
Employees
1,470
Founded
1987
Website
smspharma.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-1.6% 0.5% 6.2% 35% 37% 71%

News

Loading...

Markets

Exchange Ticker Price
National Stock Exchange of India
MIC: XNSE
PRIMARY
SMSPHARMA
SMS Pharmaceuticals Ltd
ISIN: INE812G01025
Shares Out.:
93.652M1 Shares Float: 11.99M2
TV:
SA:
YF:
GF:
BA:
MS:
403.70 INR
Bombay Stock Exchange
MIC: XBOM
532815 (SMSPHARMA)
SMS Pharmaceuticals Ltd
ISIN: INE812G01025
TV:
SA:
YF:
GF:
BA:
MS:
409.80 INR
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About SMS Pharmaceuticals Ltd.

SMS Pharmaceuticals Limited manufactures and sells active pharmaceutical ingredients (APIs) and its intermediates in India and internationally. It offers anti-retroviral, anti-inflammatory, anti-viral, anti-diabetic, anti-fungal, anti-epileptic, anti-migraine, anti-coagulant, anti-psychotic, anti-aginal, and anti-ulcer products. It is also involved in contract research activities on peptides. The company exports its products to approximately 75 countries. SMS Pharmaceuticals Limited was incorporated in 1987 and is headquartered in Hyderabad, India.

Similar Companies

Industry: Drug Manufacturers - General (India)
Name
Market Cap diff.
PE
$44.57B
4.27T INR
11K%
39.1
DIVISLAB
$18.12B
1.73T INR
4K%
70.0
$14.95B
1.43T INR
4K%
63.0
$11.57B
1.11T INR
3K%
19.6
MANKIND
$9.73B
931.67B INR
2K%
52.2
ZYDUSLIFE
$9.57B
916.53B INR
2K%
18.6
Industry: Drug Manufacturers - General (Global)
Name
Market Cap diff.
PE
LLY
$761.68B
190K%
38.1
JNJ
$547.28B
136K%
26.4
ABBV
$360.63B
90K%
97.4
$324.68B
256.25B CHF
81K%
19.9
AZN
$289.43B
215.59B GBP
72K%
27.6
NOVN
$277.35B
218.9B CHF
69K%
20.5
chevron_leftBack